Latest filing published 11 Feb 2026 for CORCEPT THERAPEUTICS INC, €492k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Hazel Hunt: trading record in brief
Hazel Hunt, listed as senior executive, appears in our data through filings on Corcept Therapeutics Inc shares, published by SEC (Form 4). In total, 19 filings cover trades dated from 24 November 2020 to 9 February 2026.
The open-market record consists of 1 sale worth €579k, with no purchase. Other entries cover 9 share grants and 9 option exercises.
On 11 February 2026 came the latest disclosure, a share grant for €2.7M in Corcept Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hazel Hunt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$3.8821.1% of flowCommon StockSEC:0001193125-26-046881:0
- 150,000 shares@ US$3.2926.1% of flowCommon StockSEC:0000950170-25-020219:0
- 60,000 shares@ US$2.818.5% of flowCommon StockSEC:0000950170-24-091049:0
- 50,000 shares@ US$3.027.5% of flowCommon StockSEC:0000950170-24-004343:0
- 20,455 shares@ US$30.88531.5% of flowCommon StockSEC:0000950170-23-042785:0
- 50,000 shares@ US$3.027.5% of flowCommon StockSEC:0000950170-23-040803:0
- 50,000 shares@ US$2.085.8% of flowCommon StockSEC:0000899243-22-032305:0
- 40,000 shares@ US$3.325.0% of flowCommon StockSEC:0000899243-22-003573:0
- 50,000 shares@ US$2.895.2% of flowCommon StockSEC:0000899243-21-028678:0
9 of 9 declarations
